Abstract
Wound healing is a multistage process involving collaborative efforts of different cell types and distinct cellular functions. Among others, the high metabolic activity at the wound site requires the formation and sprouting of new blood vessels (angiogenesis) to ensure an adequate supply of oxygen and nutrients for a successful healing process. Thus, a cutaneous wound healing model was established to identify new factors that are involved in vascular formation and remodeling in human skin after embryonic development. By analyzing global gene expression of skin biopsies obtained from wounded and unwounded skin, we identified a small set of genes that were highly significant differentially regulated in the course of wound healing. To initially investigate whether these genes might be involved in angiogenesis, we performed siRNA experiments and analyzed the knockdown phenotypes using a scratch wound assay which mimics cell migration and proliferation in vitro. The results revealed that a subset of these genes influence cell migration and proliferation in primary human endothelial cells (EC). Furthermore, histological analyses of skin biopsies showed that two of these genes, ALBIM2 and TMEM121, are colocalized with CD31, a well known EC marker. Taken together, we identified new genes involved in endothelial cell biology, which might be relevant to develop therapeutics not only for impaired wound healing but also for chronic inflammatory disorders and/or cardiovascular diseases.
Similar content being viewed by others
References
Adams RH, Alitalo K (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8(6):464–478
Herbert SP, Stainier DY (2011) Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol 12(9):551–564
Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298–307
Phng LK, Gerhardt H (2009) Angiogenesis: a team effort coordinated by notch. Dev Cell 16(2):196–208
Gerhardt H (2008) VEGF and endothelial guidance in angiogenic sprouting. Organogenesis 4(4):241–246
Jakobsson L et al (2010) Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat Cell Biol 12(10):943–953
Inai T et al (2004) Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 165(1):35–52
Bergers G, Song S (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 7(4):452–464
Armulik A, Abramsson A, Betsholtz C (2005) Endothelial/pericyte interactions. Circ Res 97(6):512–523
Gurtner GC et al (2008) Wound repair and regeneration. Nature 453(7193):314–321
Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341(10):738–746
Freinkel RK (2001) The biology of the skin. Parthenon Publishing Group, New York
Mendonca RJ (2012) Angiogenesis in wound healing. Tissue regeneration—from basic biology to clinical application
Eming SA et al (2007) Regulation of angiogenesis: wound healing as a model. Prog Histochem Cytochem 42(3):115–170
DiPietro LA (2013) Angiogenesis and scar formation in healing wounds. Curr Opin Rheumatol 25(1):87–91
Gronniger E et al (2010) Aging and chronic sun exposure cause distinct epigenetic changes in human skin. PLoS Genet 6(5):e1000971
Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3(6):1101–1108
Bronneke S et al (2012) DNA methylation regulates lineage-specifying genes in primary lymphatic and blood endothelial cells. Angiogenesis 15(2):317–329
Kiistala U (1968) Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol 50(2):129–137
Kool J et al (2007) Suction blister fluid as potential body fluid for biomarker proteins. Proteomics 7(20):3638–3650
Kanitakis J (2002) Anatomy, histology and immunohistochemistry of normal human skin. Eur J Dermatol 12(4):390–399; quiz 400–401
Fritsch P (2004) Aufbau und Funktionen der Haut. In: Dermatologie und Venerologie. Springer, Berlin. 2. Auflage
Braverman IM (1997) The cutaneous microcirculation: ultrastructure and microanatomical organization. Microcirculation 4(3):329–340
Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83(3):835–870
Nissen NN et al (1998) Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152(6):1445–1452
Brown LF et al (1992) Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176(5):1375–1379
Liang CC, Park AY, Guan JL (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2(2):329–333
Vitorino P, Meyer T (2008) Modular control of endothelial sheet migration. Genes Dev 22(23):3268–3281
Brown NJ et al (2002) Angiogenesis induction and regression in human surgical wounds. Wound Repair Regen 10(4):245–251
Roy S et al (2007) Transcriptome-wide analysis of blood vessels laser captured from human skin and chronic wound-edge tissue. Proc Natl Acad Sci USA 104(36):14472–14477
Cooper L et al (2005) Wound healing and inflammation genes revealed by array analysis of `macrophageless’ PU.1 null mice. Genome Biol 6(1):R5
Chen L et al (2010) Positional differences in the wound transcriptome of skin and oral mucosa. BMC Genomics 11:471
Roy S et al (2008) Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. Physiol Genomics 34(2):162–184
Sullivan TP et al (2001) The pig as a model for human wound healing. Wound Repair Regen 9(2):66–76
Rodero MP, Khosrotehrani K (2010) Skin wound healing modulation by macrophages. Int J Clin Exp Pathol 3(7):643–653
Morris MR et al (2010) Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene 30(12):1390–1401
Zhou J et al (2005) A novel six-transmembrane protein hhole functions as a suppressor in MAPK signaling pathways. Biochem Biophys Res Commun 333(2):344–352
Barrientos T et al (2007) Two novel members of the ABLIM protein family, ABLIM-2 and -3, associate with STARS and directly bind F-actin. J Biol Chem 282(11):8393–8403
Carmeliet P, Tessier-Lavigne M (2005) Common mechanisms of nerve and blood vessel wiring. Nature 436(7048):193–200
Presta M et al (2005) Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16(2):159–178
Boilly B et al (2000) FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev 11(4):295–302
Peterson SM et al (2010) Human Sulfatase 2 inhibits in vivo tumor growth of MDA-MB-231 human breast cancer xenografts. BMC Cancer 10:427
Baluk P, Hashizume H, McDonald DM (2005) Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15(1):102–111
Ozawa MG et al (2008) Beyond receptor expression levels: the relevance of target accessibility in ligand-directed pharmacodelivery systems. Trends Cardiovasc Med 18(4):126–132
Ai X et al (2007) SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esophageal innervation. Development 134(18):3327–3338
Acknowledgments
We thank Sonja Wessel, Boris Kristof, and Thomas Lange for helpful discussions and support concerning capillary microscopy and analyses.
Conflict of interest
All authors were employees at Beiersdorf at the time point of the study. B. Brückner received consultation fees from Beiersdorf.
Author information
Authors and Affiliations
Corresponding author
Additional information
Elke Grönniger and Marc Winnefeld have contributed equally.
Electronic supplementary material
Below is the link to the electronic supplementary material.
10456_2015_9472_MOESM1_ESM.pptx
Supplementary material 1 S1 Preprocessing of the microarray data. Flowchart showing the different steps in the microarray experiments and the preprocessing of the microarray data. (PPTX 57 kb)
10456_2015_9472_MOESM2_ESM.pptx
Supplementary material 2 S2 FGFR-1 knockdown reduced endothelial wound closure in vitro. a Expression of FGFR-1 after siRNA-induced knockdown was analyzed 24 h after transfection using qRT-PCR. b The Relative Wound Density in % of scrambled siRNA-transfected blood endothelial cells was compared with siFGFR-1-transfected cells, 30 h after cell scraping. The Relative Wound Density of control-transfected cells was set as 100% and is shown as the dotted line. The horizontal black lines denote medians and whiskers the 2.5th and 97.5th percentiles. Significant differences are indicated by asterisks. * = p ≤ 0.05; ** = p ≤ 0.01; *** = p ≤ 0.001 (unpaired t test). N (scrambled) = 10, n(siFGFR-1) = 6. c Primary endothelial cell viability was measured using Cell-Titer-Blue-Cell Viability Assay (Promega). The data were normalized to scrambled siRNA which is marked as the dotted line. As a negative control, we used cells which were treated with cis-diammineplatinum(II)dichloride (10 µg/mL) for 24 h. n = 12–24. (PPTX 55 kb)
10456_2015_9472_MOESM3_ESM.pptx
Supplementary material 3 S3 Efficiency of siRNA-induced gene knockdown. Primary endothelial cells were transfected with 3 different siRNAs per gene, indicated by the number 1, 2, or 3 (only the two most potent ones are depicted). Expression of siRNA-induced knockdown of a ABLIM2, b GGCT, c SULF2, d TMEM121, and e ZSCAN18 were analyzed 24 h after transfection using qRT-PCR. Knockdown of the corresponding genes was compared to scrambled siRNA-transfected endothelial cells, which were set to 100 %. The horizontal black lines denote medians and whiskers the 2.5th and 97.5th percentiles. Significant differences are indicated by asterisks. * = p ≤ 0.05; ** = p ≤ 0.01; *** = p ≤ 0.001 (unpaired t test). n = 6. (PPTX 76 kb)
10456_2015_9472_MOESM4_ESM.pptx
Supplementary material 4 S4 Cell viability and apoptotic activity after siRNA knockdown. Primary endothelial cells were transfected with 3 different siRNAs per gene, indicated by the number 1, 2, or 3 (only the two most potent ones are depicted). a Cell viability was analyzed 48 h after knockdown of the following genes: ABLIM2, GGCT, SULF2, TMEM121, ZSCAN18, and FGFR-1. Scrambled siRNA-transfected endothelial cells served as controls and were set to 100 %. b Apoptotic activity was determined 48 h after knockdown. For a positive control, cell populations were cultivated for 24 h in the presence of staurosporine. (PPTX 147 kb)
10456_2015_9472_MOESM5_ESM.pptx
Supplementary material 5 S5 Proliferative effects in in vitro wound closure. To analyze the effects of proliferation, cell nuclei were counted via propidium iodide staining. The impact of gene knockdown of a ABLIM2, b GGCT, c SULF2, d TMEM121, and e ZSCAN18 was studied. The left panel shows the results from the first, and the right panel the results from the second screen. The average value of the scrambled control is shown as the dotted line. The horizontal black lines denote medians and whiskers the 2.5th and 97.5th percentiles. Comparison between scrambled siRNA- and siFGFR-1-transfected cells was significant with p ≤ 0,001 (asterisks not shown). Significant differences are indicated by asterisks. * = p ≤ 0.05; ** = p ≤ 0.01; *** = p ≤ 0.001 (unpaired t test). n (per single siRNA) = 6. (PPTX 75 kb)
10456_2015_9472_MOESM6_ESM.pptx
Supplementary material 6 S6 Histological analysis of ABLIM2 and TMEM121. Images captured by immunofluorescence microscopy are shown for one representative volunteer. Skin samples were taken 2 weeks after suction blistering and embedded in paraffin. For DNA staining, Hoechst 33342 was used. a) (Co)localization of CD31, ABLIM2. Bar 50 µm. b) (Co)localization of CD31, ABLIM2 in a higher resolution. Bar: 20 µm. c) (Co)localization of CD31, TMEM121. Bar 50 µm. d) (Co)localization of CD31, TMEM121 in a higher resolution. Bar: 20 µm. (PPTX 1425 kb)
10456_2015_9472_MOESM7_ESM.pptx
Supplementary material 7 S7 Expression of ABLIM2, GGCT, SULF2, TMEM121, and ZSCAN18 in different tissues and cell types. The heat map shows the expression intensities (in percent) of the selected genes normalized to GAPDH intensities (Gene Intensity / GAPDH Intensity * 100). The mean values of 5 or 3 independent microarray experiments have been determined. Color code: blue = highly expressed; red = slightly expressed. (PPTX 43 kb)
10456_2015_9472_MOESM9_ESM.xlsx
Supplementary material 9 Table S2: Differentially expressed genes between wounded and unwounded skin that are enriched in the “Function Angiogenesis.” The analysis has been conducted using the Ingenuity software. (XLSX 15 kb)
10456_2015_9472_MOESM10_ESM.xlsx
Supplementary material 10 Table S3: List of the 48 genes, which are differentially expressed between unwounded (co) and wounded (sb) skin as well as expressed in primary human dermal endothelial cells. Three different siRNAs (Qiagen) were tested per gene. Target sequences are listed, respectively. (XLSX 24 kb)
10456_2015_9472_MOESM11_ESM.xlsx
Supplementary material 11 Table S4: RNA expression differences (FC) of the 48 genes between unwounded skin and skin 2 weeks after wounding. (XLSX 17 kb)
10456_2015_9472_MOESM12_ESM.xlsx
Supplementary material 12 Table S5: RNA expression differences (FC) of the 5 genes between unwounded and wounded skin are listed over time of the wound healing process. Positive data reflect repression, whereas negative data reflect increased expression of the associated gene in sb vs. co. (XLSX 15 kb)
Rights and permissions
About this article
Cite this article
Brönneke, S., Brückner, B., Söhle, J. et al. Genome-wide expression analysis of wounded skin reveals novel genes involved in angiogenesis. Angiogenesis 18, 361–371 (2015). https://doi.org/10.1007/s10456-015-9472-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10456-015-9472-7